We are live on ! Find out more
CRBP icon

Corbus Pharmaceuticals
CRBP

63 hedge funds and large institutions have $1.32M invested in Corbus Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

275% more call options, than puts

Call options by funds: $30K | Put options by funds: $8K

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

0.31% less ownership

Funds ownership: 0.62% → 0.32% (-0.31%)

2% less funds holding

Funds holding: 64 → 63 (-1)

21% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 14

66% less capital invested

Capital invested by funds: $3.86M → $1.32M (-$2.54M)

Holders
63
Holders Change
-1
Holders Change %
-1.56%
% of All Funds
1.01%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
11
Reduced
14
Closed
10
Calls
$30K
Puts
$8K
Net Calls
+$22K
Net Calls Change
-$12K

Top Buyers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
+$57.5K
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
+$24.9K
3
TSS
Two Sigma Securities
New York
+$10.8K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$8.23K
5
SF
Synovus Financial
Georgia
+$6.41K

Top Sellers

Rank Fund Capital Flow
1
KCM
Knoll Capital Management
Florida
-$833K
2
EMG
ETF Managers Group
New Jersey
-$777K
3
PA
Pinnacle Associates
New York
-$104K
4
Renaissance Technologies
Renaissance Technologies
New York
-$88.2K
5
Mirae Asset Global Investments
Mirae Asset Global Investments
South Korea
-$66K
Name Holding Trade Value Shares
Change 		Change in
Stake
BFM
26
Boothbay Fund Management
New York
$4.41K – – –
JEST
27
JTC Employer Solutions Trustee
Jersey
$4K – – –
Mercer Global Advisors
28
Mercer Global Advisors
Colorado
$4K – – –
Royal Bank of Canada
29
Royal Bank of Canada
Ontario, Canada
$4K +$204 +53 +5%
Envestnet Asset Management
30
Envestnet Asset Management
Illinois
$3.76K +$4.36K +1,133 New
Bank of New York Mellon
31
Bank of New York Mellon
New York
$3.54K -$285 -74 -6%
SPC
32
Sigma Planning Corp
Michigan
$3.54K – – –
CWA
33
CJM Wealth Advisers
Virginia
$3.37K – – –
UBS Group
34
UBS Group
Switzerland
$3.3K -$1.61K -418 -29%
IA
35
IFP Advisors
Florida
$3K +$12 +3 +30%
BRWA
36
B. Riley Wealth Advisors
Florida
$2.37K +$2.74K +713 New
Neuberger Berman Group
37
Neuberger Berman Group
New York
$2.21K – – –
PA
38
Pinnacle Associates
New York
$2.05K -$104K -26,956 -98%
ECM
39
ExodusPoint Capital Management
New York
$2K -$44.3K -11,523 -95%
HighTower Advisors
40
HighTower Advisors
Illinois
$2K – – –
HSA
41
HBK Sorce Advisory
Pennsylvania
$2K +$1.76K +458 New
KAS
42
Kestra Advisory Services
Texas
$1.86K +$200 +52 +10%
AWM
43
Aries Wealth Management
Maine
$1.7K – – –
GL
44
Graypoint LLC
New York
$1.48K – – –
SG
45
StoneX Group
New York
$1.45K +$1.68K +437 New
AWAG
46
ARS Wealth Advisors Group
Florida
$1.1K – – –
CG
47
Cutler Group
California
$1K – – –
Citadel Advisors
48
Citadel Advisors
Florida
$762 +$885 +230 New
HWM
49
HighMark Wealth Management
Minnesota
$495 – – –
CHA
50
Carmichael Hill & Associates
Maryland
$332 – – –
1
2
3

CRBP Hedge Fund Activity: Q4 2022 in Review

63 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Corbus Pharmaceuticals (CRBP) for Q4 2022, worth a combined $1.32M — down 66% from $3.86M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new CRBP positions and 10 closed out — a net gain of 1 holder — while 11 added to existing stakes and 14 trimmed.

The largest buyer was Two Sigma Investments, adding an estimated $57.5K. The largest seller was Knoll Capital Management, exiting entirely with an estimated $833K sold.

  • 63 institutional investors held Corbus Pharmaceuticals (CRBP) as of Q4 2022, down from 64 in Q3 2022.
  • Funds reported $1.32M of Corbus Pharmaceuticals stock for Q4 2022, down 66% quarter-over-quarter.
  • 11 funds opened new Corbus Pharmaceuticals positions in Q4 2022 and 10 closed out, a net change of +1 holder.
  • The largest Corbus Pharmaceuticals buyer in Q4 2022 was Two Sigma Investments, an estimated $57.5K added.
  • The largest Corbus Pharmaceuticals seller in Q4 2022 was Knoll Capital Management, an estimated $833K sold.

Based on aggregated 13F filings for Q4 2022.